NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/12/2025
Back to search
Official data from USPTO
COSUNTER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
08/12/2025
Trademark type
Word
Nice classes
5
Filing date
09/03/2024
Registration date
08/12/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/12/2025
Last transaction
08/12/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Fujian, CN
Examiner
MOLINOFF, JEFFREY S.
Law office
N40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
FUJIAN COSUNTER PHARMACEUTICAL CO., LTD.
Representatives
Michelle P. Ciotola Cantor Colburn LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Nutritive substances for microorganisms for medical purposes; Medicines made of Chinese traditional medicinal herbsfor the treatment of COVID-19upper respiratory tract infectionschest congestionshortness of breathchronic chest diseasesfeverinfluenzatracheitiscancerhepatitiscirrhosisliver diseases and disordersgallstoneshepatopathyAcquired Immune Deficiency Syndrome (AIDS)gastritisgastralgiapoor appetitemuscle weaknessabdominal distensionerectile dysfunctionpremature ejaculationbenign prostatic hyperplasiathrombuspulmonary embolismhypercholesterolemiaadiposityinsomniaamnesiaasthenianeurastheniavertigocough; Medicinal preparations for human usethe treatment of COVID-19upper respiratory tract infectionschest congestionshortness of breathchronic chest diseasesfeverinfluenzatracheitiscancerhepatitiscirrhosisliver diseases and disordersgallstoneshepatopathyAcquired Immune Deficiency Syndrome (AIDS)gastritisgastralgiapoor appetitemuscle weaknessabdominal distensionerectile dysfunctionpremature ejaculationbenign prostatic hyperplasiathrombuspulmonary embolismhypercholesterolemiaadiposityinsomniaamnesiaasthenianeurastheniavertigocough; Drugs for medical purposesmedicaments for the treatment of COVID-19upper respiratory tract infectionschest congestionshortness of breathchronic chest diseasesfeverinfluenzatracheitiscancerhepatitiscirrhosisliver diseases and disordersgallstoneshepatopathyAcquired Immune Deficiency Syndrome (AIDS)gastritisgastralgiapoor appetitemuscle weaknessabdominal distensionerectile dysfunctionpremature ejaculationbenign prostatic hyperplasiathrombuspulmonary embolismhypercholesterolemiaadiposityinsomniaamnesiaasthenianeurastheniavertigocough; Pharmaceutical preparationsfor the treatment of COVID-19upper respiratory tract infectionschest congestionshortness of breathchronic chest diseasesfeverinfluenzatracheitiscancerhepatitiscirrhosisliver diseases and disordersgallstoneshepatopathyAcquired Immune Deficiency Syndrome (AIDS)gastritisgastralgiapoor appetitemuscle weaknessabdominal distensionerectile dysfunctionpremature ejaculationbenign prostatic hyperplasiathrombuspulmonary embolismhypercholesterolemiaadiposityinsomniaamnesiaasthenianeurastheniavertigocough; Crude drugsmedicinal preparations for the treatment of COVID-19upper respiratory tract infectionschest congestionshortness of breathchronic chest diseasesfeverinfluenzatracheitiscancerhepatitiscirrhosisliver diseases and disordersgallstoneshepatopathyAcquired Immune Deficiency Syndrome (AIDS)gastritisgastralgiapoor appetitemuscle weaknessabdominal distensionerectile dysfunctionpremature ejaculationbenign prostatic hyperplasiathrombuspulmonary embolismhypercholesterolemiaadiposityinsomniaamnesiaasthenianeurastheniavertigocough; Biochemical medicinal preparations for the treatment of COVID-19upper respiratory tract infectionschest congestionshortness of breathchronic chest diseasesfeverinfluenzatracheitiscancerhepatitiscirrhosisliver diseases and disordersgallstoneshepatopathyAcquired Immune Deficiency Syndrome (AIDS)gastritisgastralgiapoor appetitemuscle weaknessabdominal distensionerectile dysfunctionpremature ejaculationbenign prostatic hyperplasiathrombuspulmonary embolismhypercholesterolemiaadiposityinsomniaamnesiaasthenianeurastheniavertigocough; Medicinal tea; Dietetic foods and beverages adapted for medical use; Dietetic preparations adapted for medical purpose
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/12/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/24/2025
PUBO
PUBLISHED FOR OPPOSITION
06/24/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/18/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/21/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/13/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/13/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/13/2025
DOCK
ASSIGNED TO EXAMINER
04/07/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/21/2025
GNRT
NON-FINAL ACTION E-MAILED
03/21/2025
CNRT
NON-FINAL ACTION WRITTEN
03/21/2025
DOCK
ASSIGNED TO EXAMINER
03/06/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/03/2024
NWAP
NEW APPLICATION ENTERED
09/03/2024
Continuous trademark protection
Get notified about every new filing that threatens COSUNTER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.